Lv69
2030 积分 2022-11-21 加入
Clinicopathologic Factors Associated With Response to Neoadjuvant Anti-HER2-Directed Chemotherapy in HER2-Positive Breast Cancer
4天前
已完结
The next generation of antibody–drug conjugates
5天前
已完结
Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer
11天前
已完结
Innovations in HER2-targeted therapy: A comprehensive review of trastuzumab deruxtecan
12天前
已完结
Early versus deferred use of CDK4/6 inhibitors in advanced breast cancer
13天前
已完结
中国BRCA1/2突变阳性和突变阴性乳腺癌病理学特征的比较性研究
18天前
已关闭
Clinical aspect of male breast cancer: a burgeoning and unaddressed issue
18天前
已完结
Advances in systemic therapies for triple negative breast cancer
19天前
已关闭
Novel Pharmacological Approaches to Target Mitochondrial Metabolism and DNA Damage Response in Colorectal Cancer and their Synergism with Established Chemotherapeutics
19天前
已完结
Ovarian cancer after breast cancer in women with a BRCA1 or BRCA2 pathogenic variant
1个月前
已完结
皖公网安备34019202002308
